Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients with Extensive Disease of Small Cell Lung Cancer

被引：0
|
作者：
Igawa, S. [1 ]
Fukui, T. [1 ]
Shirasawa, M. [1 ]
Ozawa, T. [1 ]
Sone, H. [1 ]
Kusuhara, S. [1 ]
Nishinarita, N. [1 ]
Hiyoshi, Y. [1 ]
Kubota, M. [1 ]
Mitsufuji, H. [2 ]
Sasaki, J. [3 ]
Katagiri, M. [4 ]
Naoki, K. [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan
[2] Kitasato Univ, Sch Nursing, Sagamihara, Kanagawa, Japan
[3] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Sagamihara, Kanagawa, Japan
[4] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Small Cell Lung Cancer; Elderly patients; Performance status; Amrubicin;
D O I：
10.1016/j.jtho.2018.08.837
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.12-02
引用
收藏
页码：S573 / S573
页数：1
相关论文
共 50 条
  • [1] Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer
    Igawa, Satoshi
    Otani, Sakiko
    Ryuge, Shinichiro
    Fukui, Tomoya
    Nakahara, Yoshiro
    Hiyoshi, Yasuhiro
    Ishihara, Mikiko
    Kusuhara, Seiichiro
    Harada, Shinya
    Mitsufuji, Hisashi
    Kubota, Masaru
    Sasaki, Jiichiro
    Masuda, Noriyuki
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (05) : 642 - 648
  • [2] Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer
    Satoshi Igawa
    Sakiko Otani
    Shinichiro Ryuge
    Tomoya Fukui
    Yoshiro Nakahara
    Yasuhiro Hiyoshi
    Mikiko Ishihara
    Seiichiro Kusuhara
    Shinya Harada
    Hisashi Mitsufuji
    Masaru Kubota
    Jiichiro Sasaki
    Noriyuki Masuda
    Investigational New Drugs, 2017, 35 : 642 - 648
  • [3] Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer
    Igawa, Satoshi
    Ryuge, Shinichiro
    Fukui, Tomoya
    Otani, Sakiko
    Kimura, Yuka
    Katono, Ken
    Takakura, Akira
    Kubota, Masaru
    Mitsufuji, Hisashi
    Katagiri, Masato
    Yanase, Nobuo
    Masuda, Noriyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (05) : 447 - 452
  • [4] Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer
    Satoshi Igawa
    Shinichiro Ryuge
    Tomoya Fukui
    Sakiko Otani
    Yuka Kimura
    Ken Katono
    Akira Takakura
    Masaru Kubota
    Hisashi Mitsufuji
    Masato Katagiri
    Nobuo Yanase
    Noriyuki Masuda
    International Journal of Clinical Oncology, 2010, 15 : 447 - 452
  • [5] Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective study
    Sone, Hideyuki
    Igawa, Satoshi
    Kasajima, Masashi
    Ishihara, Mikiko
    Hiyoshi, Yasuhiro
    Hosotani, Shinji
    Ohe, Shuntaro
    Ito, Hiroki
    Kaizuka, Nobuki
    Manaka, Hiroya
    Fukui, Tomoya
    Mitsufuji, Hisashi
    Kubota, Masaru
    Katagiri, Masato
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    THORACIC CANCER, 2018, 9 (10) : 1279 - 1284
  • [6] Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance status
    Igawa, Satoshi
    Shirasawa, Masayuki
    Ozawa, Takahiro
    Nishinarita, Noriko
    Okuma, Yuriko
    Ono, Taihei
    Sugimoto, Ai
    Kurahayashi, Shintaro
    Sugita, Keisuke
    Sone, Hideyuki
    Fukui, Tomoya
    Mitsufuji, Hisashi
    Kubota, Masaru
    Katagiri, Masato
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    THORACIC CANCER, 2018, 9 (08) : 967 - 973
  • [7] A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER
    Kinoshita, Akitoshi
    Tomonaga, Nanae
    Saijo, Tomoyuki
    Ikeda, Takaya
    Fukuda, Minoru
    Nakamura, Yoichi
    Senju, Hiroaki
    Nakano, Hirofumi
    Kitazaki, Takeshi
    Ogawara, Daiki
    Taniguchi, Hirokazu
    Motoshima, Kohei
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Shimada, Midori
    Nagashima, Seiji
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    RESPIROLOGY, 2014, 19 : 155 - 155
  • [8] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
    Takaya Ikeda
    Minoru Fukuda
    Yoichi Nakamura
    Akitoshi Kinoshita
    Hiroaki Senju
    Hirofumi Nakano
    Takeshi Kitazaki
    Daiki Ogawara
    Hirokazu Taniguchi
    Kohei Motoshima
    Hiroyuki Yamaguchi
    Katsumi Nakatomi
    Midori Shimada
    Seiji Nagashima
    Kazuhiro Tsukamoto
    Shigeru Kohno
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 497 - 502
  • [9] A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER
    Ikeda, Takaya
    Taniguchi, Hirokazu
    Soda, Hiroshi
    Fukuda, Minoru
    Kinoshita, Akihito
    Fukuda, Masaaki
    Soejima, Yoshifumi
    Ogawara, Daiki
    Nakamura, Yoichi
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1157 - S1157
  • [10] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
    Ikeda, Takaya
    Fukuda, Minoru
    Nakamura, Yoichi
    Kinoshita, Akitoshi
    Senju, Hiroaki
    Nakano, Hirofumi
    Kitazaki, Takeshi
    Ogawara, Daiki
    Taniguchi, Hirokazu
    Motoshima, Kohei
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Shimada, Midori
    Nagashima, Seiji
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 497 - 502
12345